Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
<< Kim stated this in Letter to Shareholders >>
First, it was a "Letter to Shareholders", which means it wasn't posted publicly (via a PR).
Second, the Kings / MtheMovement contract was signed in Nov 2020. That "letter" was written in May 2023, over 3 years later.
Third, "slowed down" is a blatant lie, since they never started anything to begin with. There was never any marketing, since there was never any product. Even though a website was promised in "the coming weeks", nothing every appeared.
It is ridiculous to even try to defend stuff like this. But I understand that it is meant for the drinkers of the Kool-Aid. LOL.
All that will matter for this stock and company is all that has ever mattered -- which is what they have yet to accomplish in any meaningful way:
production and sales.
The market goes "Meh" and shrugs its collective shoulders at each of these so-called PRs. When the broader market recognizes that there is something to be excited about, that's when things will move.
Production and sales.
Outstanding news to get after returning from taking my family to the beach for a week.
This new facility has the capacity for 25 metric tonnes of production per year! So, since it has 8 times the capacity of the other facility, that means the other facility was capable of producing over 3 metric tonnes per year. And they are already looking at expanding for additional production capacity in 2025 for even more production NEEDS and DEMANDS.
KBLB is about to be huge!
The uses for KBLB's Spider Silk are almost endless. Clothing, military, medical.
Very exciting times folks.
Looking forward to many more vacations soon. :)
KBLB is making what no others can.
Beyond Kong and Very Strong!
MCA
Only buys today till now....Imagine a stock full of potential, the holy grail in the fibre industry, hold down by mms manipulating the pps......Once a big buy comes in, many investors just looking at the chart will jump in this stock, till now, mms still have the control, but we longs know what we have here, a GAME CHANGER FOR THE TEXTILE INDUSTRY.......
These PRs do nothing for new investors as I believe we will see little change in
trading and the continuing low volume. All Kim has to say “we have xxx amount
in inventory”and we are on pace to achieve metric ton production by years end
and volume and pps rise would follow upwards but he can’t even do that. Pathetic.
I guess it must be “top secret”
Patrik
Not being a jersey but...i believe it said that the additional facility ALONE has the annual capacity to 25 metric tons correct?
Correct me if I am wrong.
A buyout..OMG ! You have to be kidding me. All I’ve ever heard for years is wait till productions is announced , it’s going to go thru the roof…. Well, they announced production., have you seen the share price today?… down she went… have you people not caught on yet every time Thompson opens his mouth down, she goes … nobody trust this man it’s apparent….games, people… games
That’s what Thompson is good at, and he’s very good at it
I heard the buyout price was just a bit higher: $20 TRILLION.
A little spider told me…
When you post a reply to one of my posts, you have some obligation to read and understand what I say.
For example, in spite of your declaration, I did NOT say that KBLB would be unable to produce at metric ton levels this year. I said they would struggle to meet those goals. That is to say, meeting such a goal would be difficult for KBLB, not a walk in the park.
Reading today’s PRs, KBLB now has the facilities that “when fully utilized, has the capacity to support the production of 25 metric tons of spider silk per year.”
That’s about 2 metric tons per month, right?
So KBLB is working hard to reach metric ton levels of production and will then continue the difficult challenge of ramping production up to two metric tons per month.
I get the impression you think Thompson has a magic wand that he will wave around and POOF tons upon tons of DS.
I think it will be a slog to build up their breeding pool while maintaining the quality of both the breeding pool and the resulting silk. It’s not going to happen overnight. KBLB will not be producing 2 metric tons per month in January.
The poster I was responding to claimed that KBLB would shortly be announcing production facilities in several different countries. Do you see that happening? Or do you see KBLB engaged in a challenging build-up of capacity, hiring and training new people, ensuring that all of the quality control checks are in place and being followed adequately, ensuring their food supply is not contaminated, and so on.
Rome wasn’t built in a day. KBLB will take time to scale up, especially since they haven’t answered the question: who is going to buy their silk?
Finally, be assured that I am not going to take investment advice from you and I will remind you that, even though your delicate sensibilities are wounded by my cautious posts, no one is forcing you or anyone else on this board to read them.
I have to agree with banana I think a buyout is looming ever closer. I ask this....Is a company going to want to buy us out at this price or are they going to wait until we're a few dollars per share? We are becoming more and more ripe for the picking.Our product is a game changer and ripe for BO.
Go KBLB!!! Tick tock BAM!!!!
Kong wanna be.
Kim stated this in Letter to Shareholders:
8/24/23-Things evidently aren't working out the way they were designed to.
A certain amount of money was slated for Kings to commit each year to the "cause."
They've committed NOTHING.
===========
Setting up a business, without either product or knowing if you will be able to provide any in the foreseeable future, isn't the wisest of moves.
It possesses the earmarks of OTC shenanigans.
Not saying it's a scam but certainly some of the moves are definitely "scam-adjacent."
In this particular trading arena, not a good look for KBLB.
===========
WEBSLINGER STATED:
Again check your understanding of the wording!!
This PR comes from a situation of strength in current existing production. The technology is now perfected and proven highly successful. They produced 325 lbs of cocoons many months ago, then 10x and 10x and whatever it is, but it’s major expansive!
So they say this can produce 8x current production, but this facility can produce 20tons…..think about it for a minute….they obviously only say the basics.
Imo I think some groups want a LOT?
Amen, Beach. I caught that myself. Could it be Kim giving us a hint that the great reveal IS coming? He is very cryptic sometimes in his wording. It is one of the things I love about him. As we know, KBLB's share price is a joke. We should be trading at .25 right now. Sooner or later the blind will see, and those lacking common sense will actually finally get some. GO KBLB!
No it quite clearly is not. It is reporting progress from the September 9th PR, stating the facility is NOW COMPLETE and “proudly announces the initiation of its first production cycle for the BAM-1 parental strains at its newly established production center.”
And “when fully utilized, has the capacity to support the production of 25 metric tons of spider silk per year.”
This is happening, whether you like it (I do) or not (you don’t, for whatever reason(s)).
Sorry to disappoint…
Might be time to start looking for a new gig..
Calling today’s PR a 'rehash' of the September 9th one is nothing more than a lazy attempt to downplay actual progress. If you bothered to read beyond the headlines, you’d notice some key differences: the September 9th PR focused on the completion and preparation of the facility, while today’s PR announced the launch of full-scale production. That's a major leap forward—something you conveniently gloss over to fit your 'wash, rinse, repeat' narrative.
I get it, though, it’s easier to pretend nothing's changed when the facts don’t support a doom-and-gloom agenda. The truth is, KBLB has transitioned from prepping the facility to actually producing spider silk at a capacity that can scale to meet market demands. Which is actually what they will wash, rinse, and repeat!
There are several things that stand out in the following excerpt.
Wrong. It announced PRODUCTION HAS BEGUN in the facility.
The key is production. Saying that a facility is capable of producing X metric tons doesn’t mean anything. They actually have to produce silk. Remember when they put this out in 2020?
The difference between 2020 and 2024 is that in 2020 the worms weren’t ready for prime time and COVID was killing not just people but KBLB’s progress and innovation. Now in 2024, KBLB has a successful BAM1 silkworm strain which, if everything goes well, will lead to metric ton production and SALES!!! Prepare for the harvest!!!
THIS NEWS COULDN'T BE MORE BULLISH!!!!!!!
I like this panic from one of the daily naysayers about today's pr, and i can understand all his efforts filled with lies and bs to talk today's great news down.......feels so good!
Today's PR is basically a rehash of the PR on 9 Sep:
https://www.kraiglabs.com/kraig-biocraft-laboratories-completes-new-production-center-expands-capacity-more-than-eightfold/
Wash, rinse, repeat....
Holy crap! "This new facility boasts a footprint eight times larger than its previous facility and, when fully utilized, has the capacity to support the production of 25 metric tons of spider silk per year. This transition to a larger facility marks a pivotal moment in the Company’s growth and its commitment to transforming the textile industry."
25 tons of SS per year! As I said before, the key to a BO or to an up list is production, and I said it would take a long time to achieve. This is why short-sighted investors are selling. They lack patience. Once all the pieces of production are in place, and we are so close, then the world will be KBLB's. A BO could occur at anytime from this point on. GO KBLB!
Keep twisting. KBLB's talking about NOW and the future. For those following along appropriately, 2024...2025...2026...and on and on. Foundation set for continuous, sustainable operations. The goal since inception. Buh-bye Naysayers! 👏👏👏
<< 2025 >>
Yes, the Douchebag CEO is now talking about 2025....
It looks like 2024 is a bust....
Imagine that....
Wash, rinse, repeat....
<< this one is presently large enough for 8 times more production >>
8x more than what? 5-10 kilos (which is basically all they have produced so far)?
And it is smaller than the 2019 facility that was supposed to deliver 40 metric tons per year:
https://www.kraiglabs.com/kraig-biocraft-laboratories-spider-silk-facility-to-break-corporate-production-capacity-records-within-first-months-of-operation/
Wash, rinse, repeat....
Yeah and to think this one is presently large enough for 8 times more production. How bad that is.
<< Will the next PR expose data that could be translated to a groth in volume and pps that will hold for days or even more ? >>
Sorry, but it didn't.
The Douchebag CEO moved operations to another facility (again). It's called the shell game.
Wash, rinse, repeat.....
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
ANN ARBOR, Mich., – September 23, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), proudly announces the initiation of its first production cycle for the BAM-1 parental strains at its newly established production center. This new facility boasts a footprint eight times larger than its previous facility and, when fully utilized, has the capacity to support the production of 25 metric tons of spider silk per year. This transition to a larger facility marks a pivotal moment in the Company’s growth and its commitment to transforming the textile industry.
The new production center, strategically located to optimize operations and provide easy access to supporting infrastructure, is set to accelerate the Company’s capacity for high-quality, bioengineered spider silk. This production center represents a monumental leap forward in capacity, enabling Kraig Labs to meet the demand for its groundbreaking spider silk materials and solidify its leadership in bio-engineered fibers.
This facility was built to address the production space requirements for 2025 and to create a foundation for future expansion. With this proven production blueprint established, the Company anticipates building out additional production capacity in 2025 to bring additional silk production capacity online for 2026.
“We are thrilled to embark on this new chapter in Kraig Labs’ journey,” said Company Founder and CEO, Kim Thompson. “Launching this first production cycle at this greatly expanded facility is not only a testament to our team’s dedication and hard work but also a major milestone in our mission to revolutionize material science and commercialize spider silk. Our new center will significantly enhance our production capacity, allowing us to scale up and bring our innovative spider silk technologies to a broader market.”
The launch of this production cycle and the investment into the expansion of facilities underscores the Company’s commitment to innovation and excellence in the field of bioengineered materials. With the expanded rearing capabilities, Kraig Labs aims to set new benchmarks in both production capacity and product quality, strengthening its position as a leader in the advanced materials sector.
As Kraig Biocraft Laboratories embarks on this exciting new phase, the Company extends its gratitude to its partners, investors, and team members for their unwavering support. The new production center is set to play a crucial role in driving the Company’s growth and reinforcing its position as a trailblazer in bioengineered materials.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
Will the next PR expose data that could be translated to a groth in volume and pps that will hold for days or even more ?
Photos will be great
Names will be great
If Published -> Silk prod. as much as 1-2K will plus pic. could generate a positive change imo.
KT - its your call.
We expect you to share any good news you have - if you can .
And Yes i think you can .
KBLB shareholders who have been following the narrative deserve some really big news by EOY or before.
Sad, but true, Bob…. I would bet my life that this is exactly how it went down. if it wasn’t for the fact that I got a very very cheap share price years ago, I would dump this piece of crap. The CEO has miss lead so many people over at least a decade. How in the world does he think he’s going to maintain any integrity or trust with these other companies… I can assure you they’re looking at his track record of saying one thing and then doing another… but the way he’s treated his shareholders is like he has no conscience at all… absolutely pathetic
If they don't have a grand plan then I'm with your thoughts.
The only thing that could change my thoughts at this time is a big bash planned by Both Kim and the Kings Group. If they do and the days ahead create great success on a well planned entrance then I would probably look at it different but I should say I was never that high on Kings. For me.... they will have to show me success and have a decent plan. I've been waiting for some time now.
##DUMPTHEKINGS…
$$$KBLB$$$.
KBLB investment for some went like this:
I'm Gonna Bank Investor: 'Dude, I’m buying KBLB, looks like they’ve got something big going on.'
A few days later investor: 'Why’s there no immediate return? Where’s my metric ton today?'
KBLB from inception: 'We’re scaling production, building partnerships, and setting the stage for sustainable long-term success.'
Disgruntled Investor (aka, Developmental Company of Holy Grail, Never-before-Commercialized Product Understanding Deficient): 'That’s not fast enough! I demand instant gratification! But I’ll hold my shares and stick around, just to complain about it every day. Because clearly, I can’t walk away from the potential, even while pretending I’m above it all.
It went like this
M the Movement “Dude where’s the silk? We are ready.”
Kimbo “We expect it SOON. We ANTICIPATE DOUBLING PRODUCTION, and delivery in THE CONNING MONTHS…….”
M “You mean coming months, right? Right?”
“You've said you are a businessman. Someone fails you, what do you do?”
I know what I got into. I understand the risks. I reassess the partnership and if it’s still worth remaining I continue to act as if I’m thrilled with the partnership.
I wouldn’t say what WW did even if the partnership ended. Not if I expected to be thought of as a professional.
Kings is in charge of marketing. WW is a little pussy. He publicly snubs but then whispers sweet nothings to individuals. He couldn’t possibly present himself as a more unprofessional little punk.
Dump Kings. There are real pros wanting DS
Interestingly...you haven't mentioned one plausible failure 🤣.
*****UPDATED: KBLB - FAILURE AFTER FAILURE (OR SCAM AFTER SCAM????)*****
NEW: 2024: Kings / MtheMovement Committed to Purchase Min $12 Million in Spidersilk - FAILED
NEW: 2024: GSS - FAILED
2023: Air Force Contract is a Slam Dunk - FAILED
2023: Kings / MtheMovement to Purchase Up To $12 Million in Spidersilk - FAILED
2023: Commercial production - FAILED
2022: Commercial production - FAILED
2022: Kings / MtheMovement to Purchase Up To $5 Million in Spidersilk - FAILED
2022: Website & apparel launch - FAILED
2021: Kings / MtheMovement to Purchase Up To $3 Million in Spidersilk - FAILED
2021: "The Company ... has now produced enough silk to create a number of different fabric blends." - FAILED
2021: "Spydasilk should hit the ground running" - FAILED
2021: $250K prepayment from Kings / MtheMovement- FAILED
2019-2020: Uplist to NASDAQ - FAILED
2019: Commercial production - FAILED
2019: Appoint Independent Board of Directors - FAILED
2019: Polartec MOU - FAILED
2018: "Our recombinant spider silk silkworm technology is a direct drop-in replacement for traditional silkworms and allows us to move quickly, with minimal investment, to bring new products to market" - FAILED
2018: ““We are busy preparing silkworm eggs for shipment and putting the team in place at Prodigy to hit the ground running.” - FAILED
2016-2018: Army Contract - FAILED
2016: “the Company is on schedule to produce all of the recombinant spider silk necessary to fulfill its contract with the US Government on time” - FAILED
2017: Mulberry facility in Texas - FAILED
2014-2015: "R&D .... is no longer necessary" - FAILED
2014-2015: “Scale and sale” - FAILED
2013-2015: Commercialization of Big Red - FAILED
2013-2014: Warwick Mills Partnership - FAILED
2013: SSM Industries Partnership - FAILED
And those are just a few of the MANY, MANY FAILURES that KBLB has had over the years….
Rather apparent to decipher...
KBLB announced the potentiated contract and was unable to deliver.
At first glance, it appeared the deal was going "south," when the proposed $250k obligation from Kings wasn't delivered.
It is what it is...
FAILURE TO DELIVER ON BOTH ENDS...
One had the funds but didn't...
The other couldn't produce, in order to benefit from the aforementioned contract.
MASSIVE SHARE PRICE MOVEMENT AND VOLUME INDICATES READY FOR SCALE AND SALE. DUPONT IS TOTALLY INTERESTED AND WILL BUY OUT FOR $20BN.
"you are now saying he trash talked KBLB?"
Now? I've been saying that all year long since he said it.
Kings is responsible for the marketing part of the spydasilk partnership. Yes, they need to speak up.
"Maybe Kim embarrassed them severely, promised way more than he could commit."
Right. He can get over it like we did. We understand that shit happens with development companies. That's why it's risky. We ALL know the risks. (well, most of us)
"I don't blame him for a 6 rating."
No one does. The point is that you keep your f'n mouth shut and say that stuff in house. This is business. That's how it works. It was public disrespect of a business partner. Total BS in the business world. Everyone has complaints about their partners/relatives/friends, but you don't go around telling the neighbors.
I'm sure Kim was embarrassed by the hamas bomber vest & balaclava (I know I was). It maybe will be a big hit at the Pride parade on the gaza strip, but in the west, it's kind of an embarrassing outfit.
Sure, the failure is on Kim. But it's still the partner's job to present a united front if he wants to remain partners. Kim no longer needs Kings and Wendy Wu's silent treatment pretending not to have noticed that KBLB is light years away from where they were just a year ago has grown so old. The tables have turned, it's long past time for the homecoming warrior to remember that Kim invited her to the dance.
Not deflecting at all. Addressing it all. Like usual. I see you've gone to some lengths to avoid the basics of what M4N was expressing and now I'm trying to get you to be specific on, which you whisked away as...
Followers
|
641
|
Posters
|
|
Posts (Today)
|
32
|
Posts (Total)
|
281357
|
Created
|
05/04/08
|
Type
|
Free
|
Moderators MU_Redskin1 gimmegimmeminemine TRUISM WebSlinger |
Email: corporate@KraigLabs.com
KRAIG LABS WEBSITE FOR INVESTORS
Quarterly and Annual Reporting to the SEC is available on the Company's Website and EDGAR.
* Financial Statements * SEC Filings *
Outstanding Shares as of January 12, 2023
For issues or questions relating to share certificates or the transfer of securities please contact the company's transfer agent:
Olde Monmouth Stock Transfer Co., Inc.
200 Memorial Pkwy.
Atlantic Highlands, New Jersey 07716
Phone: (732) 872-2727
(since August 14, 2013)
Kraig Biocraft Laboratories, Inc. (KBLB) is the first company with a commercially feasible spidersilk to be mass produced.
Kraig Labs is a biotechnology company focused on the development of commercially significant high performance polymers and technical fibers. Kraig Lab's focus has been on the production of a transgenic silkworm incorporating specific gene sequences from the golden orb weaving spider. These specific gene sequences inserted are to enable the silkworm to spin a new recombinant fiber which incorporates spider silk proteins. With the scientific breakthrough announced on September 29, 2010, Kraig Labs is now working to commercialize the transgenic silkworms to compete in the garment industry silk market. The value for the chinese raw silk market alone is 3-5 billion per annum. With the creation of 20 seperate transgenic silkworms, all with unique properties, Kraig Labs is now working at an accelerated pace to build upon their first generation transgenic organisms to develop their second generation of transgenic silkworm incorporating spider silk proteins. The scientists nearly doubled the strength of the silkworm with these specific spider gene insertions. Their second generation of transgenics are expected to be complete in 2011. These second generation organisms are to be compared with the strength, flexibility and resiliency of the native spider in which the gene sequences are derived from. These fibers which will match the strength of spider silk are expected to compete in the technical textiles market valued in excess of 120 billion per annum. The 3rd generation organisms are currently in the planning phase. These organisms are expected to spin fibers exceeding the strength of native spiders and may incorporate gene sequences that release an antibiotic, or to help reduce scarring with use in bandages.
Kraig Biocraft Laboratories has a sponsored research and development program with the University of Notre Dame, and the University of Wyoming. The genetic work is occurring at the University of Notre Dame, headed by Dr Malcolm Fraser, Phd. The gene sequences are derived from Dr. Randy Lewis's(University of Wyoming) patented gene sequences of the golden orb weaving spider. Kraig labs is paying for all expenses incurred for this research and development program, and thus Kraig Labs has exclusive global commercialization rights with the technologies developed, including methods, organisms, and fibers produced.
MANAGEMENT
Kim Thompson, Founder and CEO
As the CEO of the company, Mr. Thompson is the only member of the scientific advisory board who is also
a part of the corporation's management. His formal education lies in the fields of economics and law.
He received his B.A. in Applied Economics from James Madison College at Michigan State University.
He received his Juris Doctorate from the University of Michigan Law School in 1994.
Mr. Thompson founded Kraig Biocraft Laboratories in his pursuit of the development of new biotechnologies
with industrial applications. As chairman of the scientific advisory board, he brings a unique perspective,and
acts as the primary liaison between the advisory board and the corporation.
Mr. Thompson brings a wealth of experience in business management and consultation to Kraig. Following
the completion of his undergraduate degree, Mr. Thompson joined California Craftsman, Inc. as a
Vice-President with primary responsibility for both marketing and human resources.
Kim Thompson was the director of business development at Franchise Venture Partners, LLC. He subsequently
joined the firm of Shearson, Lehman, Hutton where he specialized in equity trading and research of small cap
companies. Mr. Thompson received the highest series seven score for all Shearson brokers in his class nationwide.
His experience in those small cap equity markets has proven to be invaluable both in his legal and business successes.
Prior to becoming a public company CEO, Mr. Thompson was the founder and senior litigation partner in a California
commercial law firm where he worked as corporate and litigation counsel to privately held and public companies.
His many accomplishments in corporate law include winning and collecting in full what his firm believes to have been
the largest award of lost profits in a California commercial arbitration up to that time. An important part of his work was
winning victories on behalf of corporate clients in disputes over intellectual property and distribution rights. He has
represented business clients ranging from small start ups and micro caps to Fortune 100 companies.
With a background in business leadership and in advising public and private corporations, Kim Thompson continues
to bring a unique perspective to the successful management of business. His extensive business and legal background
enables him to create practical solutions to business problems and seize opportunities for growth.
Mr. Thompson is a member of the Triple Nine Society for persons with documented genius level IQs (having tested above
the 99.9th percentile). He is also active in the realm of science and invention where he has to his credit a number of
provisional patent applications including innovations in the areas of biotechnology, organic polymers, genetic engineering
and magnetic field manipulation, among others.
Mr. Rice has over 13 years’ experience growing development stage businesses with a focus on technology development, commercialization, and go to market strategies. Mr. Rice holds a B.S. in Chemical engineering from Michigan Technological University.
Prior to joining Kraig Biocraft Laboratories Mr. Rice was the Director of Advanced Technologies for Ultra Electronics, AMI. In this role, Mr. Rice was responsible for the identification, capture, and execution of new technology programs. During his tenure with AMI, Rice secured more than twenty five million dollars in funded development programs from the US Department of Defense which his team successfully leveraged into commercially viable spinoff products. Mr. Rice was also responsible for technical sales, marketing, and promotion of AMI’s products and capabilities. Rice joined AMI as the third full time employee and helped to lead the organization through its rapid growth and ultimate acquisition by Ultra Electronics in 2011.
Earlier in his career Mr. Rice developed unique advanced manufacturing techniques, established and trained a production staff, led engineering development, authored numerous technical papers, and is a recognized subject matter expert. Mr. Rice holds 5 issued patents and numerous provisional patents.
Mr. Rice brings a history of transforming revolutionary ideas into viable commercial products.
Mr. Rice is currently completing his Masters of Business Administration through the Executive Program at the Eli Broad College of Business: Michigan State University.
Despite the huge potential of genetically modified animals outside of laboratory research, commercialisation of these animals has been extremely limited. Numerous factors, including negative consumer perception, regulatory hurdles, and limitations inherent to classical GM technologies, have kept the majority of GM animal applications within the realm of academic research. However genome editing using zinc finger nucleases could help develop new markets for the future commercialisation of GM animals.
Genetic modification is commonplace throughout the life sciences sector, from fundamental research to pharmaceutical testing. GM cellular and animal models are valuable tools for the study of many chronic diseases, the testing of pharmaceutical compounds and the development of new therapeutic strategies. Genetic modification also offers great benefits in vaccine and biopharmaceutical manufacturing, which rely heavily on the use of GM organisms for biomolecule design and production. Modifying the genome of an organism or cell line allows the incorporation of target biomolecules in specific biological contexts, as well as the transfer of a gene product from a low-producing organism to one that can produce on a commercial scale. These applications have been widely accepted for many years, with countless GM organisms approved for medical manufacturing applications by drug regulators in all major countries. Despite this widespread success within the research and pharmaceutical sectors, the use of GM organisms outside of these markets has been limited.
Despite the lack of broad acceptance for most commercial applications of GM animal products, this technology has been able to gain traction in a few market sectors. The most obvious application has been the commercialisation of transgenic animals for the production of biomolecules for therapeutic use. Cattle, sheep and goats have been used for large-scale production of antibodies, steroids and hormones - most notably insulin - for many years. In 2009, GTC Biotherapeutics received US FDA approval for bioproduction of a recombinant human antithrombin. This product - ATryn - is extracted from the milk of transgenic goats, and is the first approved biopharmaceutical to be produced using genetically engineered animals. Although this is a significant breakthrough for the commercialisation of GM animals, it is still within the pharmaceutical industry, and is a natural progression of existing cell-based technologies. Of potentially greater commercial interest is the extension of genetic engineering outside of this sector, into areas such as food production, textiles and even companion animals.
GM crops have been available in many countries since the early 1990s, and numerous cash crops - including sugar beet, soybean, corn and tomatoes - have been modified to improve resistance to disease, increase the rate of growth or enhance nutritional value. However, cultivation of these transgenic crops is generally tightly regulated, particularly within the European Union, and this, together with negative public opinion, has limited the more widespread development of GM technologies.
Similar to GM crops, many of the animals currently under development are intended to confer disease resistance, an application particularly suited to the use of zinc finger nuclease (ZFN) technology. Many diseases can be treated by the targeted deletion or modification of a host gene. With ZFNs, these targets can be modified with no footprint of genetic engineering. Due to the high costs of raising livestock, another area of focus in developing commercial GM animals has been increasing the rate of growth or size of animals. Among the first GM animals likely to be launched is a fast growing salmon from AquaBounty. The AquAdvantage Salmon is designed to reach market size in half the time of a wild type salmon, reducing costs for fish farmers and limiting the environmental impact of salmon farming by avoiding the need for ocean pens.
Although genetic engineering of animals for food is primarily driven by economic pressures, GM technologies have also been used in the companion animals market. In this sector, genetic modification can be used for practical purposes - such as the creation of hypoallergenic animals or the correction of heritable congenital defects which have arisen though inbreeding - or for purely cosmetic purposes, such as GloFish. The first example of a GM pet, GloFish are fluorescent zebrafish (Danio rerio) that have had genes encoding naturally fluorescent proteins (GFP, YFP, RFP) inserted into their genome. Developed by a group at the National University of Singapore, GloFish were originally created to develop live detection systems for water pollution. They were introduced as pets in the United States in 2003 following over two years of extensive environmental research and consultation. In Europe however, the sale and possession of GloFish is prohibited by rigorous legislation concerning the use of GM technologies.
By allowing precisely targeted insertion of spider genes and concomitant removal of endogenous silkworm silk genes at the same locus, ZFN technology offers the potential for development of transgenic silkworms which will produce native spider silk at commercially viable levels
Perhaps even more interesting from a commercial perspective is the use of GM animals in the manufacture of textiles. Silkworms - actually the larval form of the silkmoth Bombyx mori - have been used for the production of silk for thousands of years, with natural silk still produced by the cultivation of silkworms today. Silkworm cocoons are unwound to create linear silk threads, then re-spun into textiles in much the same way as cotton. Although the applications of silkworm silk are numerous, due to their unique physical and chemical properties, there is also widespread interest in the silks of several other insects.
Spider silk, in particular, offers numerous possibilities within the technical textiles industry, due to its incredible tensile strength and elasticity; characteristics which have not yet been replicated in synthetic materials. Like all insect silks, spider silk fibres consist of repetitive units of protein crystals separated by less structured protein chains. The exact properties and composition of each spider silk vary with its intended function. Major Ampullate or dragline silk, for example, is relatively hydrophobic with very high tensile strength and toughness, as it is used to form the outer rim and spokes of a web. In contrast, hydrophilic capture spiral silks, which form the inner structures of the web, are sticky and highly elastic to effectively entrap prey. This high degree of variability offers enormous potential for the textiles industry, raising the possibility of tailoring the properties of silk to create advanced technical fabrics, for applications such as bulletproof vests, parachute canopies and automobile airbags; biomedical applications, including sutures and tendon and ligament repair; new fabrics, for sportswear and clothing; and even microelectronics.
Although the use of spider silks for microsutures has recently been reported, more widespread application of spider silk technologies is currently limited by the difficulty in producing silks on a commercially viable scale. This is due to the difficulties of rearing spiders in large numbers, due to their highly territorial and cannibalistic nature. As a result, the harvesting of spider silk fibres is extremely time consuming and labour intensive, with production of the only known spider silk garment - an 11 foot by 4 foot shawl made from golden orb spider silk - taking 150 people over five years to produce and costing in excess of £300,000!
.
To overcome these limitations, and allow future development of spider silk technologies, an alternative strategy for spider silk production is required. This makes spider silk production an obvious candidate for genetic modification, inserting spider silk genes into the genome
of other silk-making insects for bioproduction. For example, random insertion of orb spider silk genes into silkworms has allowed production of hybrid spider/silkworm silk using traditional silkworm farming strategies. The resulting hybrid silk contains approximately 10% spider silk
and has greater strength and durability than native silkworm silk, raising the possibility of using transgenic silkworms to produce pure spider silks.
Though straightforward in principle, the exchange of native silkworm genes for spider silk genes, alongside more widespread exploitation of genetic engineering, has been limited by the inherent restrictions of conventional GM technologies.
The generalised process of modifying an organism requires several capabilities, including:
While many different techniques exist for accomplishing each of these steps, most GM technologies offer a compromise between the efficiency of the technique and the ability to accurately and precisely target the locus of interest. Viral genomic delivery technologies effectively deliver nucleic acids to cells and organisms, but fall short on ability to target specific regions of the genome, generally only allowing random insertion of genetic material. In comparison, transposase technologies allow a greater degree of targeting, but leave unwanted traces of exogenous DNA in their wake. Other methods involve the introduction of naked DNA into the cell, which results in insertion into the genome at very low frequencies, usually at random, limiting this approach to organisms that can be economically cultivated at high densities and screened in large numbers. Simply put, most techniques for genetic manipulation are random, inefficient and leave a 'footprint' of foreign DNA. While this is usually tolerated in basic research, it is not acceptable for most commercial applications, and has been a major hurdle for GM animal technologies to date.
The advent of zinc finger nuclease (ZFN) technology represents a significant breakthrough for commercialisation of GM animal products, offering precisely targeted, efficient genome editing for the first time. Commercially available through Sigma Life Science under the CompoZr brand, this technique can be used to create permanent and heritable changes to an organism of interest.
This high degree of variability offers enormous potential for the textiles industry, raising the possibility of tailoring the properties of silk to create advanced technical fabrics
ZFNs are a class of engineered DNA binding proteins that facilitate targeted editing of the genome by creating double-strand breaks at user-specified locations. These breaks stimulate the cell's natural DNA repair mechanisms - homologous recombination (HR) and non-homologous end joining (NHEJ) - which can be exploited to achieve rapid and permanent site-specific modification of the desired genes. While HR can be used to insert foreign DNA sequences, NHEJ allows the cell's natural processes to create precisely targeted mimics of natural mutations which leave no traces of foreign DNA. Unlike previous techniques, ZFNs offer excellent sequence specificity, binding 24 to 36 base pair target sequences to virtually eliminate off target effects, and are able to achieve modification rates exceeding 20 %, well above rates for most other technologies.
The technique is already being used to create transgenic silkworms for spider silk production. By allowing precisely targeted insertion of spider genes and concomitant removal of endogenous silkworm silk genes at the same locus, ZFN technology offers the potential for development of transgenic silkworms which will produce native spider silk at commercially viable levels.
GM technologies have revolutionised the research world and have great potential in a variety of commercial applications, but have been limited by the inherent restrictions associated with historical GM technologies. The main drawback of these technologies is their inability to accurately and efficiently target genes of interest, instead relying on random insertion of genetic material into host genomes. These limitations result in the need for extensive and costly screening to identify animals with correct transgene expression (without compromising the viability of the animal), and also result in the co-expression of both the transgene and native homologues already present.
The advent of ZFN technology signifies the beginning of an exciting new chapter in the world of genetic modification, allowing precise, targeted and efficient genome editing for the first time. Production of native spider silk using transgenic silkworms is just one example of the potential commercial applications of this innovative technology, taking us one step closer to the reality of industrial scale biomanufacturing and paving the way for an entirely new spectrum of environmentally friendly materials.
Authors:
Joseph Bedell and Brian Buntaine
Commercial Animal Technologies Group, Sigma Advanced Genetic Engineering (SAGE) Labs, Sigma Life Science
HEADLINES FOR KRAIG BIOCRAFT LABORATORIES / (KBLB):
PHOTOS FROM VIETNAM POSTED JULY 6, 2018
ANN ARBOR, Mich., – January 7, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has successfully delivered the first two shipments of its highly specialized silkworms, which produce a silk with the physical characteristics of spider silk, to Vietnam.
Today’s announcement is the culmination of more than 5 years of work, and challenging negotiation, with the government of Vietnam. The silkworms from these first two shipments have already hatched and are now enjoying a fresh mulberry diet, so, for the first time in history, the global demand for spider silk materials has a viable, cost effective, and scalable solution.
“The dream of commercializing our powerful technology is now materializing. This marks a dramatic leap forward in Kraig Labs’ business plan for commercial production and mass marketing of cost effective recombinant spider silk, and becomes the foundation for an entirely new industry,” said, COO, Jon Rice. “To our long-term shareholders, who have taken this journey with us, as well as our team in the US and Vietnam, who have worked tirelessly to make this dream a reality, I cannot thank you enough. As we start the New Year, full of new opportunity, we truly have something incredible to celebrate.”
The Company has been working with leading sericulture experts, biotechnology institutions, and governmental agencies, in Vietnam, to further boost the silk industry with our revolutionary technology. Kraig Labs is currently finalizing renovation plans for a ~46,000 square foot production factory in Quang Nam Province, Vietnam.
“Our plan has always been to bring our technology to the silk producing regions of the world for rapid scale-up,” said, CEO and Founder, Kim Thompson. “Today we see the fruits of that effort. With its massive silk infrastructure and production capacity, Vietnam is an ideal location to launch our technology scale-up. Congratulations to our team and shareholders, as we prepare for the realization of large scale production.”
\
\
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |